SCHEMBL6749075

SCHEMBL6749075

COC(=O)c1ccc2c(c1)Nc1ncccc1S2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.50
ALDH1A1 P00352 1/20 0.50
TP53 P04637 3/20 0.49
POLB P06746 1/20 0.49
THRB P10828 1/20 0.49
BLM P54132 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
MAPT P10636 4/20 0.48
ALOX15 P16050 3/20 0.48
NOX1 Q9Y5S8 3/20 0.48
HTT P42858 2/20 0.48
MEN1 O00255 2/20 0.48
GAA P10253 2/20 0.48
KMT2A Q03164 2/20 0.48
CYBB P04839 1/20 0.48
APP P05067 1/20 0.48
SNCA P37840 1/20 0.48
NOX3 Q9HBY0 1/20 0.48
NOX4 Q9NPH5 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6745635 0.84 ALDH1A1 (0.51) LMNAALDH1A1MAPTGAASMN1; SMN2
SCHEMBL6749211 0.81 ALDH1A1 (0.49) LMNAALDH1A1TP53POLBTHRB
SCHEMBL25141298 0.78 NOX1 (0.64) LMNATDP1L3MBTL1MAPTALOX15
SCHEMBL9395338 0.77 LMNA (0.58) LMNAALDH1A1TP53POLBTHRB
SCHEMBL6749725 0.77 ALDH1A1 (0.45) LMNAALDH1A1TP53POLBTHRB
SCHEMBL6751804 0.76 MAPT (0.51) LMNAALDH1A1TP53POLBTHRB
SCHEMBL4670606 0.76 TP53 (0.78) LMNAALDH1A1TP53POLBTHRB
SCHEMBL29355925 0.76 TP53 (0.78) LMNAALDH1A1TP53POLBTHRB
SCHEMBL8791121 0.74 ALDH1A1 (0.63) LMNAALDH1A1TP53POLBTHRB
SCHEMBL6752502 0.73 MAPT (0.50) LMNAALDH1A1MAPTALOX15HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040092737-A1 Benzopiperidine derivatives EISAI CO., LTD. 2004-05-13 US disclosed
US-6518423-B1 These compounds are useful as drugs efficacious in the prevention and treatment of these various inflammatory diseases and immunologic diseases, such as rheumatoid arthritis, atopic dermatitis, psoriasis, asthma, and EISAI CO., LTD. (JP) 2003-02-11 US disclosed
EP-0934941-A1 BENZOPIPERIDINE DERIVATIVES Eisai Co., Ltd. (JP) 1999-08-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040092737-A1 Benzopiperidine derivatives HLA-DRB1, HRH1, HRH2 LMNA 4878/4885ALDH1A1 145/4885TP53 550/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.